内眼疾患の英語

正常眼圧緑内障疾患感受性遺伝子及びその利用方法を提供する。例文帳に追加

To provide a normal tension glaucoma disease-sensitive gene and utilization of the same. - 特許庁

正常眼圧緑内障疾患感受性遺伝子及びその利用方法を提供する。例文帳に追加

To provide a gene sensitive to a normal-tension glaucoma disease, and a method for using the same. - 特許庁

眼内病的血管新生阻害剤、眼内血管新生性疾患の予防及び／又は治療薬、並びにそのスクリーニング方法例文帳に追加

INTRAOCULAR PATHOLOGIC NEOVASCULARIZATION INHIBITOR, MEDICINE FOR PREVENTING AND/OR TREATING INTRAOCULAR NEOVASCULARIZATION DISEASE, AND METHOD FOR SCREENING THE SAME - 特許庁

眼疾患としては、網膜血管閉塞症、糖尿病網膜症、虚血性視神経症、黄斑変性症、網膜色素変性症、レーベル病のような網膜疾患、又は緑内障などが挙げられる。例文帳に追加

Retinal diseases such as retinal vessel occlusion, diabetic retinopathy, ischemic optic neuropathy, macular degeneration, pigmentary degeneration of the retina, Leber's disease, glaucoma, etc., may be cited as the eye diseases. - 特許庁

インターフェロン−β等のタンパク性薬物を硝子体や網膜等の内眼部疾患に効果的に適用できる技術を提供する。例文帳に追加

To provide a technique by which a protein medicine such as interferon-β can effectively be applied to an internal ophthalmopathy such as a vitreous body disease or a retinal disease. - 特許庁

眼寸法の測定に必要な干渉信号のＳ／Ｎを向上させ、眼疾患（例えば、白内障眼）を持つ被検者眼であっても、眼寸法を好適に算出できる。例文帳に追加

To appropriately calculate eye dimensions of an eye of a subject with eye diseases (for example a cataract eye) by improving an S/N ratio of an interference signal required for the measurement of eye dimensions. - 特許庁

前記化合物は、例えば腫瘍又は転移性増殖、乾癬、カポジ肉腫、再狭窄、例えばステント誘発性再狭窄、子宮内膜症、クローン病、ホジキン病、白血病；関節炎、例えばリウマチ様関節炎、血管腫、血管線維腫、眼疾患、腎疾患、線維症性疾患、動脈硬化、などの治療に使用され得る。例文帳に追加

This compound can be used for the treatment of, for example, tumor or metastatic growth, psoriasis, Kaposi sarcoma, restenosis, for example, stent-induced restenosis, endometriosis, Crohn's disease, Hodgkin's disease, leukemia; arthritis, for example, rheumatoid arthritis, vascular neoplasm, angiofibroma, eye disease, renal disease, fibrotic disease, arterial sclerosis, etc. - 特許庁

血管新生を伴う疾患、特に眼科疾患における血管新生を内科的に制御し、正常な血管新生を阻害することなく治療できる、副作用が少なく、安全性が高い、血管新生疾患の治療・予防に有効な組成物、ならびにそれを用いた血管新生の制御方法を提供する。例文帳に追加

To provide a composition which has less adverse side effects, is highly safe, and effective for the treatment/prevention of angiogenic diseases in a way that it regulates angiogenesis in angiogenesis-related diseases, particularly ophthalmic diseases in a medical manner, and treats the diseases without inhibiting normal angiogenesis and a method for regulating angiogenesis using the composition. - 特許庁